FindTrial
Sign In

Discussion on the regional management of central nervous system demyelinating diseases under the internet mode

Discussion on the regional management of central nervous system demyelinating diseases under the internet mode

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094924
Enrollment
Unknown
Registered
2024-12-30
Start date
2022-04-12
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

central nervous system demyelinating diseases

Interventions

neuromyelitis optic spectrum disease group/ multiple sclerosis group:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients meeting the 2017 revised McDonald diagnostic criteria for multiple sclerosis; (2) Patients who meet the diagnostic criteria for neuromyelitis spectrum diseases established by the 2015 International Neuromyelitis Optica Diagnostic Panel; (3) Informed consent signed clinical research subjects.

Exclusion criteria

Exclusion criteria: (1) Patients who refuse to sign informed consent for clinical study subjects; (2) Due to poor patient compliance can't cooperate with the follow-up work, or incomplete clinical and radiographic data. (3) Patients with demyelinating diseases of the central nervous system consistent with other diagnoses.

Design outcomes

Primary

MeasureTime frame
Extended Disability Status Scale score;—

Secondary

MeasureTime frame
Timed-25-foot walk test;12-Item Multiple Sclerosis Walking Scale;Nine-Hole Peg Test;—

Countries

China

Contacts

Public ContactHongyu Zhou

West China Hospital, Sichuan University

zhouhy@scu.edu.cn+86 189 8060 1675

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026